Anne-Laure Cazeau is an expert in Hematology at Institut Bergonié (France). Anne-Laure Cazeau has authored 35 publications, the most recent in 2022, and is an investigator in 7 clinical trials. SLR score: 122 (community average: 125). How the SLR is computed.

LeadR Profile

Anne-Laure Cazeau Institut Bergonié France
122 ScienceLeadR Reputation 122
Network Map

Hematology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2009 - 2022

Source: PubMed

Institut Bergonié

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 35

Citations

Citations: 2 067 1st author: 0 Last author: 8 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Diagnostic accuracy and clinical impact of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in Positron Emission Tomography - Computed Tomography (PET-CT)-positive mediastinal lymphadenopathies in patients with thoracic or extra-thoracic malignancies.
PMID 35341993 — gastrointestinal diseases, needles, therapeutics, neoplasms, positron-emission tomography, endoscopic ultrasound-guided fine needle aspiration, positron emission tomography computed tomography, lymphadenopathy
Clin Res Hepatol Gastroenterol20222
Impact of FDG- PET CT in the Management of Muscle Invasive Bladder Cancer.
PMID 35101381 — kidney neoplasms, diagnosis, therapeutics, prostatic neoplasms, urinary bladder neoplasms, muscles, positron emission tomography computed tomography
Clin Genitourin Cancer202210
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
PMID 34161051 — prostate, therapeutics, prostatic neoplasms, castration, disease-free survival, progression-free survival
N Engl J Med Top journal20211,726
Diffusion-weighted MRI and PET/CT reproducibility in epithelial ovarian cancers during neoadjuvant chemotherapy.
PMID 34112625 — diffusion magnetic resonance imaging, ovary, neoplasms, drug therapy, positron emission tomography computed tomography, diagnostic imaging, ovarian neoplasms, carcinoma, ovarian epithelial, chemotherapy
Diagn Interv Imaging20217
Single-Center Experience of Focal Thermo-Ablative Therapy After Pelvic Radiotherapy for In-Field Prostate Cancer Oligo-Recurrence.
PMID 34381730 — prostate, therapeutics, prostatic neoplasms, cryotherapy, positron-emission tomography, disease-free survival, radiology, interventional, radiotherapy, progression-free survival
Front Oncol20213

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Chair: 2

By phase:

N/A 4
Phase 2 2
Phase 3 1

By status:

Completed 6
Terminated 1

By type:

Interventional 7

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 1
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map